Maryland Oncology Hematology, P.A is a clinical research site located in Frederick, Maryland, United States 21702.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
Maryland Oncology Hematology, P.A has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Non-small Cell Lung Cancer, Advanced Breast Cancer, Metastatic Breast Cancer.
Sponsors: Effector Therapeutics, Pfizer, Seagen, a wholly owned subsidiary of Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Maryland · View every site in Frederick
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Maryland Oncology Hematology, P.A has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Maryland Oncology Hematology, P.A has 3 clinical trials on record, with 1 currently active. Their work covers Non-small Cell Lung Cancer, Advanced Breast Cancer, Metastatic Breast Cancer.
Maryland Oncology Hematology, P.A has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.